Despite UK High Court setback for Pfizer, Arrow declarations remain a valuable litigation tool

The latest judgment is one of only a few to provide an indication of when the courts will grant the pre-emptive litigation defence remedy, which was issued for the first time in 2017

Get unlimited access to all IAM content